MOLECULAR MARKERS OF SENSITIVITY AND RESISTANCE OF COLORECTAL CANCER TO ANTI-EGFR T
Targeted therapy of metastatic colorectal cancer lacks predictive markers with positive predictive value, i.e. the selection of potentially responsive patients remains highly complicated. In contrast, there are very reliable markers indicating resistance to the therapy by anti-EGFR antibodies. Asses...
Saved in:
| Main Authors: | A. O. Ivantsov, G. A. Yanus, E. N. Suspitsin, E. I. Anisimova, E. N. Imyanitov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2016-04-01
|
| Series: | Сибирский онкологический журнал |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/311 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinicopathological Characteristics of Colorectal Cancer Patients with Different Mismatch Repair Statuses and Their Correlation with KRAS/NRAS/BRAF Gene Mutations
by: Jinchuan YU, et al.
Published: (2024-11-01) -
Heterogeneity and clonal evolution of colorectal cancer
by: M. Yu. Fedyanin, et al.
Published: (2017-04-01) -
INFLUENCE OF SOMATIC MUTATIONS OF KRAS, NRAS, BRAF AND MICROSATELLITE INSTABILITY STATUS ON SURVIVAL OF COLORECTAL CANCER PATIENTS WITH PERITONAL CARCINO
by: V. P. Shubin, et al.
Published: (2020-10-01) -
Site‐Specific Mutations on KRAS, NRAS, and BRAF Corelate With the Frequency of ctDNA in Colorectal Cancer
by: Fumihiro Yoshimura, et al.
Published: (2025-07-01) -
In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-free DNA in the blood of melanoma patients receiving immune checkpoint inhibition
by: Isabel Heidrich, et al.
Published: (2025-07-01)